58:41

59.Subanesthetic Ketamine Suppresses Locus Coeruleus–Mediated Alertness Effects: A 7T fMRI Study

33:06

R-Ketamine for Treatment Resistant Depression

33:15

Ketamine vs. ECT: implications for clinical practice, policy and future research

56:49

058.Ketamine alleviates NMDA receptorhypofunction through synaptic trapping

30:16

Opioid use reduces placebo response independently of pain in a ketamine depression trial

30:07

Long-term safety and durable efficacy of esketamine in TRD and ESCAPE-TRD

31:13

Addiction potential of ketamine enantiomers and metabolites, and of esmethadone

29:53

Prucalopride (5HT4a agonist) plus ketamine: additive effects on stress